FDA Says Philips Respironics Recalls V60 And V60 Plus Ventilators Due To Power Management Printed Circuit Board Assemblies (PM PCBAs) Not Meeting Ventilator Standards
Portfolio Pulse from Benzinga Newsdesk
Philips Respironics, a subsidiary of Philips (PHG), is recalling its V60 and V60 Plus ventilators due to their Power Management Printed Circuit Board Assemblies (PM PCBAs) not meeting ventilator standards. The FDA has classified this as a Class I recall, the most serious type, as use of these devices may cause serious injuries or death. However, no deaths or injuries have been reported so far. The recall is a voluntary correction, not a product removal.
October 20, 2023 | 4:58 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Philips' subsidiary, Philips Respironics, is recalling its V60 and V60 Plus ventilators due to non-compliance with standards. This could potentially harm Philips' reputation and financial performance in the short term.
The recall of a product, especially one classified as a Class I recall by the FDA, can have a negative impact on a company's reputation and financial performance. This is due to potential lawsuits, the cost of the recall, and lost sales. Although no injuries or deaths have been reported, the potential for serious harm could lead to a loss of trust in Philips' products.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100